| 2018 ESC/EACTS Guidelines on myocardial revascularization FJ Neumann, M Sousa-Uva, A Ahlsson, F Alfonso, AP Banning, ... European heart journal 40 (2), 87-165, 2019 | 7921 | 2019 |
| 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the … J Knuuti, W Wijns, A Saraste, D Capodanno, E Barbato, ... European heart journal 41 (3), 407-477, 2020 | 7118 | 2020 |
| 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute … JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ... European heart journal 42 (14), 1289-1367, 2021 | 5413 | 2021 |
| Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis JL Mega, T Simon, JP Collet, JL Anderson, EM Antman, K Bliden, ... Jama 304 (16), 1821-1830, 2010 | 1413 | 2010 |
| Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate L Bonello, US Tantry, R Marcucci, R Blindt, DJ Angiolillo, R Becker, ... Journal of the American College of Cardiology 56 (12), 919-933, 2010 | 1356 | 2010 |
| A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of … M Seyfarth, D Sibbing, I Bauer, G Fröhlich, L Bott-Flügel, R Byrne, ... Journal of the American College of Cardiology 52 (19), 1584-1588, 2008 | 1125 | 2008 |
| Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding US Tantry, L Bonello, D Aradi, MJ Price, YH Jeong, DJ Angiolillo, ... Journal of the American College of Cardiology 62 (24), 2261-2273, 2013 | 927 | 2013 |
| Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis D Sibbing, S Braun, T Morath, J Mehilli, W Vogt, A Schömig, A Kastrati, ... Journal of the American College of Cardiology 53 (10), 849-856, 2009 | 816 | 2009 |
| Cytochrome 2C19* 17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement D Sibbing, W Koch, D Gebhard, T Schuster, S Braun, J Stegherr, T Morath, ... Circulation 121 (4), 512-518, 2010 | 778 | 2010 |
| Ticagrelor or prasugrel in patients with acute coronary syndromes S Schüpke, FJ Neumann, M Menichelli, K Mayer, I Bernlochner, J Wöhrle, ... New England Journal of Medicine 381 (16), 1524-1534, 2019 | 762 | 2019 |
| 2018 ESC/EACTS Guidelines on myocardial revascularization M Sousa-Uva, FJ Neumann, A Ahlsson, F Alfonso, AP Banning, ... European Journal of Cardio-Thoracic Surgery 55 (1), 4-90, 2019 | 653 | 2019 |
| Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel D Sibbing, T Morath, J Stegherr, S Braun, W Vogt, M Hadamitzky, ... Thrombosis and haemostasis 101 (04), 714-719, 2009 | 621 | 2009 |
| Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention D Sibbing, J Stegherr, W Latz, W Koch, J Mehilli, K Dörrler, T Morath, ... European heart journal 30 (8), 916-922, 2009 | 609 | 2009 |
| Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label … D Sibbing, D Aradi, C Jacobshagen, L Gross, D Trenk, T Geisler, M Orban, ... The Lancet 390 (10104), 1747-1757, 2017 | 579 | 2017 |
| 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and … S Halvorsen, J Mehilli, S Cassese, TS Hall, M Abdelhamid, E Barbato, ... European heart journal 43 (39), 3826-3924, 2022 | 527 | 2022 |
| Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial KA Fiedler, M Maeng, J Mehilli, S Schulz-Schüpke, RA Byrne, D Sibbing, ... Journal of the American College of Cardiology 65 (16), 1619-1629, 2015 | 515 | 2015 |
| Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary … D Sibbing, D Aradi, D Alexopoulos, J Ten Berg, DL Bhatt, L Bonello, ... JACC: Cardiovascular Interventions 12 (16), 1521-1537, 2019 | 467 | 2019 |
| European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism C Pristipino, H Sievert, F D’ascenzo, J Louis Mas, B Meier, P Scacciatella, ... European Heart Journal 40 (38), 3182-3195, 2019 | 417 | 2019 |
| International Expert Consensus on Switching Platelet P2Y12 Receptor–Inhibiting Therapies DJ Angiolillo, F Rollini, RF Storey, DL Bhatt, S James, DJ Schneider, ... Circulation 136 (20), 1955-1975, 2017 | 404 | 2017 |
| Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary … D Aradi, A Kirtane, L Bonello, PA Gurbel, US Tantry, K Huber, ... European heart journal 36 (27), 1762-1771, 2015 | 404 | 2015 |
Adnan KastratiDeutsches Herzzentrum München在 dhm.mhn.de 的电子邮件经过验证
